European Medicines Agency (EMA) virtual press briefing -HPV Safety Review 2015

Jun 23, 2017 | Video

European Medicines Agency (EMA) virtual press briefing – Human papillomavirus (HPV) vaccines

Recommendation from the Pharmacovigilance Risk Assessment Committee (PRAC), 5th November 2015

Comparing reported Adverse Reactions to vaccines in UK

Independent-graph

Follow Us

Recent Tweets

RT @deddingtonian: @talkRADIO @JuliaHB1 @Iromg Totally agree that susceptibility to an ADR from COVID vaccine or any other should be resear…
6 days ago • Reply • Retweet • Favorite
RT @deddingtonian: @freddiesayers Excellent, intelligent, balanced interview. Vaccine damage happens. Informed consent is key with the risk…
2 weeks ago • Reply • Retweet • Favorite
RT @clare_ramagge: Reminiscent of an article about my daughter with ME following #hpv vaccine. That was 10 Yrs ago. She is totally bedbound…
2 weeks ago • Reply • Retweet • Favorite
RT @caronryalls: @clare_ramagge Few people realise that as well as being a post-viral illness, vaccination can also cause ME type condition…
2 weeks ago • Reply • Retweet • Favorite
RT @picphysicians: Did you know that different HPV types not targeted by the HPV vaccine are becoming more common? spandidos-publications.com/ol/12/1/601…
3 weeks ago • Reply • Retweet • Favorite

Follow @TimeForActionUK

Pin It on Pinterest

Share This